Automated GSP™ Genetic Screening Processor enables multi-analyte analysis, accelerates sample screening and increases accuracy WALTHAM, Mass. — PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company has received 510K clearance from the U.S. Food and Drug Administration for its GSP™ Genetic Screening Processor, […]
CHICAGO — New imaging technology using one of the world’s smallest flexible microscopes enables physicians to look — at the cellular level — at living, moving tissue in the lungs and gastrointestinal tract so they can make a rapid diagnosis or carefully select tissue for biopsy. With the probe-based, confocal, laser-endomicroscopy system known as Cellvizio(R), […]
The MitoDx test is much more accurate than any test currently available and will aid in the detection of mitochondrial diseases. Los Angeles, CA — MEDomics Senior Scientist Carolyn H. Buzin and MEDomics Senior Scientist Fan Chen, Ph.D., Medomics Chief Technical Officer and mutation expert, traveled to Taipei, Taiwan to provide a featured 45-minute presentation […]
BOSTON–Enzo Biochem Inc. (NYSE:ENZ) announced today that favorable results of the Company’s clinical trial for treatment of non-alcoholic steatohepatitis (NASH) were presented at the annual meeting of the American Association for the Study of Liver Diseases. The study was a randomized double blind placebo controlled format of EGS21, Enzo’s orally administered beta glucosylceramide formulation, designed […]
NEW YORK — Xenomics, Inc. (Pink Sheets:XNOM.PK)(FWB:XE7) a developer of trans-renal molecular diagnostic technologies, announced today that it has filed a complaint against Sequenom, Inc. (Nasdaq: SQNM) in the Supreme Court of the State of New York alleging that Sequenom fraudulently misrepresented to Xenomics the status of its testing for Down Syndrome and based upon […]
Company is advancing point-of-care, molecular diagnostic infectious disease applications REDMOND, Wash. — Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics� products that incorporate Biosearch�s proprietary fluorophores and […]
Business Combination Adds Cutting-Edge Product Lines and Expands International Operations San Diego, California and Vienna, Austria — eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI), commonly known as a heart attack. Copeptin, developed by recently acquired B.R.A.H.M.S. AG, is a patented biomarker […]
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros. The terms of the agreement were not disclosed at this time. The transaction is […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
